Highlights
KLSE: EDEN (7471)       EDEN INC BHD MAIN : Utilities
Last Price Today's Change   Day's Range   Trading Volume
0.13   -0.005 (3.70%)  0.13 - 0.135  1,657,300
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 51 Million

Market Cap 51 Million
NOSH 391 Million

Latest Audited Result:  31-Dec-2017

Latest Audited Result: 31-Dec-2017
Announcement Date 30-Apr-2018
Next Audited Result: 31-Dec-2018
Est. Ann. Date: 30-Apr-2019
Est. Ann. Due Date: 29-Jun-2019

Latest Quarter:  31-Dec-2018 [#4]

Latest Quarter: 31-Dec-2018 [#4]
Announcement Date 28-Feb-2019
Next Quarter: 31-Mar-2019
Est. Ann. Date: 31-May-2019
Est. Ann. Due Date: 30-May-2019
QoQ | YoY   99.63%  |    99.79%

Annual (Unaudited) ( EPS: -2.05, P/E: -6.33 )

Revenue | NP to SH 62,787  |  -8,024
RPS | P/RPS 16.06 Cent  |  0.81
EPS | P/E | EY -2.05 Cent  |  -6.33  |  -15.79%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.64  |  0.20
YoY   51.37%
NP Margin | ROE -14.54%  |  -3.24%
F.Y. | Ann. Date 31-Dec-2018  |  28-Feb-2019

T4Q Result ( EPS: -2.05, P/E: -6.33 )

Revenue | NP to SH 61,998  |  -8,027
RPS | P/RPS 15.86 Cent  |  0.82
EPS | P/E | EY -2.05 Cent  |  -6.33  |  -15.80%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.63  |  0.21
QoQ | YoY   37.38%  |    51.38%
NP Margin | ROE -14.73%  |  -3.24%
F.Y. | Ann. Date 31-Dec-2018  |  28-Feb-2019

Annualized Result ( EPS: -2.05, P/E: -6.33 )

Revenue | NP to SH 62,787  |  -8,024
RPS | P/RPS 16.06 Cent  |  0.81
EPS | P/E | EY -2.05 Cent  |  -6.33  |  -15.79%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   24.91%  |    51.37%
NP Margin | ROE -14.54%  |  -3.24%
F.Y. | Ann. Date 31-Dec-2018  |  28-Feb-2019




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 62,787 61,998 62,787 51,931 51,278 51,076 69,739 91,631 91,701 173,282 211,381 227,407 -13.32%
  YoY % 1.27% -1.26% 20.90% 1.27% 0.40% -26.76% -23.89% -0.08% -47.08% -18.02% -7.05% -
  Horiz. % 27.61% 27.26% 27.61% 22.84% 22.55% 22.46% 30.67% 40.29% 40.32% 76.20% 92.95% 100.00%
PBT -10,350 -10,351 -10,350 -12,588 -16,410 30,849 -13,345 4,054 12,951 19,359 -8,675 4,296 -
  YoY % 0.01% -0.01% 17.78% 23.29% -153.19% 331.17% -429.18% -68.70% -33.10% 323.16% -301.93% -
  Horiz. % -240.92% -240.95% -240.92% -293.02% -381.98% 718.09% -310.64% 94.37% 301.47% 450.63% -201.93% 100.00%
Tax 1,221 1,220 1,221 -4,675 -6,550 -78,054 4,249 -10,705 -2,234 -8,656 4,627 -2,684 -
  YoY % 0.08% -0.08% 126.12% 28.63% 91.61% -1,937.00% 139.69% -379.19% 74.19% -287.08% 272.39% -
  Horiz. % -45.49% -45.45% -45.49% 174.18% 244.04% 2,908.12% -158.31% 398.85% 83.23% 322.50% -172.39% 100.00%
NP -9,129 -9,131 -9,129 -17,263 -22,960 -47,205 -9,096 -6,651 10,717 10,703 -4,048 1,612 -
  YoY % 0.02% -0.02% 47.12% 24.81% 51.36% -418.96% -36.76% -162.06% 0.13% 364.40% -351.12% -
  Horiz. % -566.32% -566.44% -566.32% -1,070.91% -1,424.32% -2,928.35% -564.27% -412.59% 664.83% 663.96% -251.12% 100.00%
NP to SH -8,024 -8,027 -8,024 -16,500 -23,061 -46,447 -9,191 -6,810 10,655 11,067 -3,150 1,576 -
  YoY % 0.04% -0.04% 51.37% 28.45% 50.35% -405.35% -34.96% -163.91% -3.72% 451.33% -299.87% -
  Horiz. % -509.14% -509.33% -509.14% -1,046.95% -1,463.26% -2,947.14% -583.19% -432.11% 676.08% 702.22% -199.87% 100.00%
Tax Rate - % - % - % - % - % 253.02 % - % 264.06 % 17.25 % 44.71 % - % 62.48 % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1,430.78% -61.42% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 0.00% 404.96% 0.00% 422.63% 27.61% 71.56% 0.00% 100.00%
Total Cost 71,916 71,129 71,916 69,194 74,238 98,281 78,835 98,282 80,984 162,579 215,429 225,795 -11.93%
  YoY % 1.11% -1.09% 3.93% -6.79% -24.46% 24.67% -19.79% 21.36% -50.19% -24.53% -4.59% -
  Horiz. % 31.85% 31.50% 31.85% 30.64% 32.88% 43.53% 34.91% 43.53% 35.87% 72.00% 95.41% 100.00%
Net Worth 247,756 247,756 247,756 245,975 261,544 233,521 280,225 289,566 295,793 283,285 253,660 328,745 -3.09%
  YoY % 0.00% 0.00% 0.72% -5.95% 12.00% -16.67% -3.23% -2.11% 4.42% 11.68% -22.84% -
  Horiz. % 75.36% 75.36% 75.36% 74.82% 79.56% 71.03% 85.24% 88.08% 89.98% 86.17% 77.16% 100.00%
Dividend
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div - 0 - - - - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
Div Payout % - % - % - % - % - % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
Equity
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 247,756 247,756 247,756 245,975 261,544 233,521 280,225 289,566 295,793 283,285 253,660 328,745 -3.09%
  YoY % 0.00% 0.00% 0.72% -5.95% 12.00% -16.67% -3.23% -2.11% 4.42% 11.68% -22.84% -
  Horiz. % 75.36% 75.36% 75.36% 74.82% 79.56% 71.03% 85.24% 88.08% 89.98% 86.17% 77.16% 100.00%
NOSH 321,762 321,762 321,762 311,362 311,362 311,362 311,362 311,362 311,362 311,303 310,363 313,090 0.30%
  YoY % 0.00% 0.00% 3.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.30% -0.87% -
  Horiz. % 102.77% 102.77% 102.77% 99.45% 99.45% 99.45% 99.45% 99.45% 99.45% 99.43% 99.13% 100.00%
Ratio Analysis
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -14.54 % -14.73 % -14.54 % -33.24 % -44.78 % -92.42 % -13.04 % -7.26 % 11.69 % 6.18 % -1.92 % 0.71 % -
  YoY % 1.29% -1.31% 56.26% 25.77% 51.55% -608.74% -79.61% -162.10% 89.16% 421.88% -370.42% -
  Horiz. % -2,047.89% -2,074.65% -2,047.89% -4,681.69% -6,307.04% -13,016.90% -1,836.62% -1,022.54% 1,646.48% 870.42% -270.42% 100.00%
ROE -3.24 % -3.24 % -3.24 % -6.71 % -8.82 % -19.89 % -3.28 % -2.35 % 3.60 % 3.91 % -1.24 % 0.48 % -
  YoY % 0.00% 0.00% 51.71% 23.92% 55.66% -506.40% -39.57% -165.28% -7.93% 415.32% -358.33% -
  Horiz. % -675.00% -675.00% -675.00% -1,397.92% -1,837.50% -4,143.75% -683.33% -489.58% 750.00% 814.58% -258.33% 100.00%
Per Share
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 19.51 19.27 19.51 16.68 16.47 16.40 22.40 29.43 29.45 55.66 68.11 72.63 -13.58%
  YoY % 1.25% -1.23% 16.97% 1.28% 0.43% -26.79% -23.89% -0.07% -47.09% -18.28% -6.22% -
  Horiz. % 26.86% 26.53% 26.86% 22.97% 22.68% 22.58% 30.84% 40.52% 40.55% 76.64% 93.78% 100.00%
EPS -2.46 -2.49 -2.46 -5.30 -7.41 -14.92 -2.95 -2.19 3.42 3.55 -1.37 0.51 -
  YoY % 1.20% -1.22% 53.58% 28.48% 50.34% -405.76% -34.70% -164.04% -3.66% 359.12% -368.63% -
  Horiz. % -482.35% -488.24% -482.35% -1,039.22% -1,452.94% -2,925.49% -578.43% -429.41% 670.59% 696.08% -268.63% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
NAPS 0.7700 0.7700 0.7700 0.7900 0.8400 0.7500 0.9000 0.9300 0.9500 0.9100 0.8173 1.0500 -3.39%
  YoY % 0.00% 0.00% -2.53% -5.95% 12.00% -16.67% -3.23% -2.11% 4.40% 11.34% -22.16% -
  Horiz. % 73.33% 73.33% 73.33% 75.24% 80.00% 71.43% 85.71% 88.57% 90.48% 86.67% 77.84% 100.00%
Adjusted Per Share Value based on latest NOSH - 390,861
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 16.06 15.86 16.06 13.29 13.12 13.07 17.84 23.44 23.46 44.33 54.08 58.18 -13.32%
  YoY % 1.26% -1.25% 20.84% 1.30% 0.38% -26.74% -23.89% -0.09% -47.08% -18.03% -7.05% -
  Horiz. % 27.60% 27.26% 27.60% 22.84% 22.55% 22.46% 30.66% 40.29% 40.32% 76.19% 92.95% 100.00%
EPS -2.05 -2.05 -2.05 -4.22 -5.90 -11.88 -2.35 -1.74 2.73 2.83 -0.81 0.40 -
  YoY % 0.00% 0.00% 51.42% 28.47% 50.34% -405.53% -35.06% -163.74% -3.53% 449.38% -302.50% -
  Horiz. % -512.50% -512.50% -512.50% -1,055.00% -1,475.00% -2,970.00% -587.50% -435.00% 682.50% 707.50% -202.50% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
NAPS 0.6426 0.6339 0.6426 0.6293 0.6691 0.5975 0.7169 0.7408 0.7568 0.7248 0.6490 0.8411 -2.94%
  YoY % 1.37% -1.35% 2.11% -5.95% 11.98% -16.66% -3.23% -2.11% 4.42% 11.68% -22.84% -
  Horiz. % 76.40% 75.37% 76.40% 74.82% 79.55% 71.04% 85.23% 88.08% 89.98% 86.17% 77.16% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date AQR T4Q 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 0.0950 0.0950 0.0950 0.1750 0.1800 0.2250 0.2500 0.3200 0.2800 0.3100 0.4000 0.3800 -
P/RPS 0.49 0.49 0.49 1.05 1.09 1.37 1.12 1.09 0.95 0.56 0.59 0.52 -0.66%
  YoY % 0.00% 0.00% -53.33% -3.67% -20.44% 22.32% 2.75% 14.74% 69.64% -5.08% 13.46% -
  Horiz. % 94.23% 94.23% 94.23% 201.92% 209.62% 263.46% 215.38% 209.62% 182.69% 107.69% 113.46% 100.00%
P/EPS -3.81 -3.81 -3.81 -3.30 -2.43 -1.51 -8.47 -14.63 8.18 8.72 -39.41 75.49 -
  YoY % 0.00% 0.00% -15.45% -35.80% -60.93% 82.17% 42.11% -278.85% -6.19% 122.13% -152.21% -
  Horiz. % -5.05% -5.05% -5.05% -4.37% -3.22% -2.00% -11.22% -19.38% 10.84% 11.55% -52.21% 100.00%
EY -26.25 -26.26 -26.25 -30.28 -41.15 -66.30 -11.81 -6.83 12.22 11.47 -2.54 1.32 -
  YoY % 0.04% -0.04% 13.31% 26.42% 37.93% -461.39% -72.91% -155.89% 6.54% 551.57% -292.42% -
  Horiz. % -1,988.64% -1,989.39% -1,988.64% -2,293.94% -3,117.42% -5,022.73% -894.70% -517.42% 925.76% 868.94% -192.42% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
P/NAPS 0.12 0.12 0.12 0.22 0.21 0.30 0.28 0.34 0.29 0.34 0.49 0.36 -11.48%
  YoY % 0.00% 0.00% -45.45% 4.76% -30.00% 7.14% -17.65% 17.24% -14.71% -30.61% 36.11% -
  Horiz. % 33.33% 33.33% 33.33% 61.11% 58.33% 83.33% 77.78% 94.44% 80.56% 94.44% 136.11% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date AQR T4Q 28/02/19 28/02/18 28/02/17 29/02/16 27/02/15 28/02/14 28/02/13 01/03/12 28/02/11 25/02/10 -
Price 0.1100 0.1100 0.1100 0.1600 0.2100 0.2250 0.2400 0.3250 0.2600 0.3600 0.3800 0.4200 -
P/RPS 0.56 0.57 0.56 0.96 1.28 1.37 1.07 1.10 0.88 0.65 0.56 0.58 -0.39%
  YoY % -1.75% 1.79% -41.67% -25.00% -6.57% 28.04% -2.73% 25.00% 35.38% 16.07% -3.45% -
  Horiz. % 96.55% 98.28% 96.55% 165.52% 220.69% 236.21% 184.48% 189.66% 151.72% 112.07% 96.55% 100.00%
P/EPS -4.41 -4.41 -4.41 -3.02 -2.84 -1.51 -8.13 -14.86 7.60 10.13 -37.44 83.44 -
  YoY % 0.00% 0.00% -46.03% -6.34% -88.08% 81.43% 45.29% -295.53% -24.98% 127.06% -144.87% -
  Horiz. % -5.29% -5.29% -5.29% -3.62% -3.40% -1.81% -9.74% -17.81% 9.11% 12.14% -44.87% 100.00%
EY -22.67 -22.68 -22.67 -33.12 -35.27 -66.30 -12.30 -6.73 13.16 9.88 -2.67 1.20 -
  YoY % 0.04% -0.04% 31.55% 6.10% 46.80% -439.02% -82.76% -151.14% 33.20% 470.04% -322.50% -
  Horiz. % -1,889.17% -1,890.00% -1,889.17% -2,760.00% -2,939.17% -5,525.00% -1,025.00% -560.83% 1,096.67% 823.33% -222.50% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - - - - - - -
P/NAPS 0.14 0.14 0.14 0.20 0.25 0.30 0.27 0.35 0.27 0.40 0.46 0.40 -11.00%
  YoY % 0.00% 0.00% -30.00% -20.00% -16.67% 11.11% -22.86% 29.63% -32.50% -13.04% 15.00% -
  Horiz. % 35.00% 35.00% 35.00% 50.00% 62.50% 75.00% 67.50% 87.50% 67.50% 100.00% 115.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  Be the first to like this.
 
Ahead1268 This is just ikan bilis goreng for kopi money. Don’t get trapped.
18/10/2018 1:00 PM
lanciao 这只股票未来还有希望吗
18/10/2018 10:16 PM
likewise 没有
24/10/2018 4:54 PM
lanciao 没有最低只有更低
25/10/2018 2:05 PM
eatsmall kapalabana..
26/10/2018 11:10 AM
bleuerouge only eden still down below.
01/11/2018 11:42 PM
shareking1 Opcom, Eden, thriven, ewein all up today.
02/11/2018 9:50 AM
lanciao Come liao
02/11/2018 11:32 AM
kalezen when will it stop droping??
26/11/2018 4:09 PM
Ahead1268 Tomorrow not sure how the qtr result. If back may drop further. The share conversion at 0.116 also dump into market on 15/11 bout 0.13 x 8mil unit but seem absorbed by market.
26/11/2018 9:57 PM
Kaliz Varan Im bleeding as bought this counter too much. Not sure should i hold or run.
27/11/2018 8:24 PM
27/11/2018 10:35 PM
stockholm999 my average is 14.5cen huatt ahhh plss!
28/11/2018 8:51 AM
stockholm999 http://www.bursamalaysia.com/market/listed-companies/company-announcements/5985525

what does it mean?
28/11/2018 8:54 AM
Kaliz Varan I bought at 0.30..guess its game over for me
29/11/2018 8:53 AM
stockholm999 waa. kaliz. u lagi power than me can hold for so long.
29/11/2018 10:27 AM
chukai24 0.181 want died also lo ,QR lost also
29/11/2018 2:02 PM
chukai24 sale all at 0.11
04/12/2018 1:09 PM
kalezen why eden want to buy the leasehold property in PJ from utusan ?? for what purpose?
05/12/2018 10:35 AM
Kaliz Varan Stockholm. Do i have a choice? I invested too much to pull back
05/12/2018 6:42 PM
stockholm999 just hold, i also holding. wait golden time we sellllll!
05/12/2018 8:24 PM
Alex™ wah...10sen also mari
05/12/2018 8:47 PM
emil going to 0.030 stuck for years...
05/12/2018 10:00 PM
stockholm999 fking counter
07/12/2018 10:30 AM
Kaliz Varan Emil i wish u meant 0.30
08/12/2018 1:05 PM
stockholm999 now 10cen, cibai stock
11/12/2018 3:43 PM
commonsense Hi Kaliz,

It might be a while before the company could turnaround its financial performances.
The company has been losing money since FY13 mainly due to the disruption causes by the 60MW thermal Libaran Plant in Sabah. Most of the disruptions were related to the ageing assets of the plant itself. Since 2013 the plant has never been able to operate at full capacity as the reparation works of the plant has yet to be completed till this day. The plant still only uses 2 out of the 4 diesel engines that it needs. Reparation was slow due to lack of funds.

Things just got worst in FY15 when its Sungai Kenerong Hydro plant in Kelantan was highly affected by the major flood occurred in late 2014. Most of the transmission lines and pipelines were heavily damaged. Reparation works has yet to be completed mainly due to the lack of funds as well.

As you imagine, this has affected the company financials in particular the company balance sheet strength. As of Sept 18, the company has a total of RM405mil in assets but only RM47 mil are current asset (of which RM7.4mil only is cash). Total liabilities stand at RM162mil but RM111mil are current liabilities (of which RM51mil is debt). The company will most probably face liquidity issue in the future.

Management has come up with a fund-raising exercise via Redeemable Convertible Notes to Advance Capital Partners Asset Management (ACPAM) for a total of RM60mil. The interest rate is really low at only 1% which at first, I thought was great. But the issue is that the conversion terms to ordinary shares for ACPAM is very favourable to them. They are able to convert the notes anytime within the 3 years at a price of 80%- 90% of an average of 3 days closing price taken from a range of 45 days before the conversion decision. Floor price of conversion is 12 sens. Let say the whole RM60mil is converted into shares at the 12 sens exercise price. This would mean there will be an additional 500 mil shares to be issued later vs the current 378mil shares. This means any upside potential for current shareholder might be diluted later. And given the favourable terms, ACPAM would prefer for the share price to be depressed for them to get the lowest conversion price. Once they see the share price rallying, then they will convert and most probably sell the shares straight away. Refer to the circular on the notes below:

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5839797

That being said, till now ACPAM has only subscribe RM3mil out of the RM60 mil which itself is worrying as well. Even at favourable terms they still hesitate to subscribe to more of the Notes. Why?

If you are looking to diversify your portfolio outside of the power industry (due to the current industry sentiment), I would recommend you to look at MBMR.

MBMR is a direct proxy to Perodua via its 22.6% interest in the company. Valuation is cheap at only 5.8x PE (based on target FY18 PATAMI of RM145mil. 9m PATAMI is already RM106mil). PB is low at only 0.6x BV. 4Q18 results is expected to be higher than 3Q18 and last year's 4Q17. For FY19 growth will be driven by the still high demand of new Myvi and the launch of the new SUV in 1Q19.

Please go through the analyst reports (https://klse.i3investor.com/servlets/stk/pt/5983.jsp) and do your own analysis before making any decisions.

Good luck.
17/12/2018 10:50 AM
Kaliz Varan Hi common sense. Thank you for this information. Appreciate it.
19/12/2018 9:01 PM
Fortuneman High NTA. With 404M worth assets. Liabilities around 162M. 404M discounted 30% disposal price and deduct the liabilities each share can get about 30c. Wat to worry?
30/12/2018 2:01 AM
lanciao Eden come give ang pou
14/01/2019 12:47 AM
kentbee82 eden还会涨多一次吗
17/01/2019 8:39 PM
jackMaDe thanks for sharing on eden, commonsense
22/01/2019 5:34 PM
Michael Wong hopeless
28/01/2019 7:04 PM
lanciao Come on eden go up
13/02/2019 9:22 PM
super168 Eden please run up.
21/02/2019 3:14 PM
Mrsonic so hard to run up
21/02/2019 6:11 PM
Ester1 No up?
06/03/2019 10:34 AM
Jayden8 Something - BIG is happening soon...
11/03/2019 10:08 AM
ahlong muhidin kanser recovery...
11/03/2019 10:09 AM
Jayden8 Heard it is something very bad.. internal
11/03/2019 10:34 AM
5c0160 Faster run. Hopeless below 010 soon
14/03/2019 7:25 PM
shareking1 Today turn ---Opcom, Eden, thriven, ewein, all up
19/03/2019 9:09 AM
eatsmall manyak kuat ini hari
19/03/2019 9:17 AM
Karlos It is just a beginning!!
19/03/2019 9:20 AM
kenie Muhyiddin recovering well after cancer surgery
Tan Sri Muhyiddin Yassin, who is undergoing chemotherapy after a bout of pancreatic cancer, says he is well on the road to recovery.
PAGOH: Home Minister Tan Sri Muhyiddin Yassin, who is undergoing chemotherapy after a bout of pancreatic cancer, says he is well on the road to recovery.
"Alhamdulillah (Thanks be to God), I am 60 per cent recovered after undergoing a surgery to remove a growth on my pancreas and several sessions of chemotherapy," said the Pagoh member of parliament here today.
Muhyiddin also said he has undergone four out of eight rounds of chemotherapy. It was reported that the treatment would last six months to prevent a relapse.
The former deputy prime minister also said he was fully ready to continue working and serving the country.
"Actually, it has been a long time since I gave a speech but today, I would like to let the people of Pagoh know about my health. The doctors confirmed that I had first-stage pancreatic cancer and advised me to remove the tumour.
"Forty per cent of my pancreas has been removed. My duodenum and bile duct was also removed. I need four more rounds of chemotherapy within the next four months.
"Alhamdulillah, I can now visit my constituency after the first four sessions of chemotherapy. I can now attend Cabinet meetings, party meetings and chair meetings on foreign immigrants," he told constituents during a meet-the-people event at Pagoh Multipurpose Hall here today.
Present were his wife Puan Sri Norainee Abd Rahman and Johor Health, Environment and Agriculture Committee chairman Dr Sahruddin Jamal.
More than 600 constituents attended Muhyiddin's event. This is his first public appearance in Pagoh since undergoing a surgery Mount Elizabeth Hospital in Singapore on July 12.
The Parti Pribumi Bersatu Malaysia president said his health continued to improve after resuming his duties as Pagoh MP on Aug 14.
"When I was unwell, felt week, dizzy and vomitting, I took lots of rest at home and focused on performing acts of worship.
"But when I felt stronger and told my doctor I wanted to return to Pagoh, he was worried that I might catch an infection," he added
19/03/2019 9:21 AM
stockholm999 finalllyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyy, i sold at 15 cen. dammnnn. earn half cen. =D if u see back the comment.. is like 2018 i been waiting till now
19/03/2019 9:22 AM
lanciao Balik rumah bakar ikan loh.....
19/03/2019 3:38 PM
stockholm999 i guess today show done. back to sleeping mode hibernate mode
20/03/2019 8:26 AM
stockholm999 round 2
20/03/2019 9:13 AM
fl888 Muhyddin son is in the company, what to worry, sure fly to break 15 today, moreover based in Sabah and Sarawak which has so much economic news nowadays....
22/03/2019 8:06 AM